Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Global Blood Therapeutics (GB:0IVZ)
LSE:0IVZ
Global Blood Therapeutics (0IVZ) Share Price & Analysis
0 Followers
0IVZ Stock Chart & Stats
Day’s Range$68.48 - $68.48
52-Week Range― - ―
Previous Close$68.48
Volume0.00
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding67,476,179
10 Day Avg. Volume92
30 Day Avg. Volume152
Standard Deviation13.25
R-Squared0.01
Alpha2.25
Financial Highlights & Ratios
Price to Book (P/B)39.05
Price to Sales (P/S)18.18
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-24.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$68.58Price Target Upside0.15% Upside
Rating ConsensusHold
Number of Analyst Covering14
Global Blood Therapeutics News
Stock Analysis & Ideas3 “Strong Buy” Stocks to Watch as 2Q22 Kicks Off
0IVZ FAQ
What was Global Blood Therapeutics’s price range in the past 12 months?
Currently, no data Available
What is Global Blood Therapeutics’s market cap?
Currently, no data Available
When is Global Blood Therapeutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Global Blood Therapeutics’s earnings last quarter?
Currently, no data Available
Is Global Blood Therapeutics overvalued?
According to Wall Street analysts Global Blood Therapeutics’s price is currently Undervalued.
Does Global Blood Therapeutics pay dividends?
Global Blood Therapeutics does not currently pay dividends.
What is Global Blood Therapeutics’s EPS estimate?
Global Blood Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Global Blood Therapeutics have?
Currently, no data Available
What happened to Global Blood Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Global Blood Therapeutics?
Among the largest hedge funds holding Global Blood Therapeutics’s share is Perceptive Advisors LLC. It holds Global Blood Therapeutics’s shares valued at 96M.
---
Global Blood Therapeutics Stock Smart Score
Company Description
Global Blood Therapeutics
Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA.
---
Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.
---